Palliative Care Yields Cancer Wellbeing Support

NCT06259136 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1050

Last updated 2025-07-28

No results posted yet for this study

Summary

The goal of this study is to evaluate the effectiveness of a programme for transitional palliative cancer care (Pal-Cycles) in seven countries (the Netherlands, Germany, United Kingdom, Hungary, Poland, Romania and Portugal) and its consequent effects on the number of readmissions into hospital.

The main hypothesis for the study is: that fewer people in the intervention arm of the study will require hospital re admission than those having usual care.

Participants will be asked to fill in questionnaires regarding their quality of care and quality of life.

Conditions

Interventions

PROCEDURE

A transitional palliative care intervention

The Pal-Cycles intervention starts just before the care transition from curative oncology care to palliative care with a goals of care conversation between a hospital care provider and the patient. The conversation will be recorded in a summary of treatment and care form which will be completed by a hospital based clinician based on the key elements of the conversation with the patient and the treatment and care plan. Afterwards a (digital) copy of the form is given to the patient and another copy is sent to the general practitioner in combination with the discharge letter.

Sponsors & Collaborators

  • Lancaster University

    collaborator OTHER
  • University Hospital, Bonn

    collaborator OTHER
  • University of Navarra

    collaborator OTHER
  • University in Zielona Góra

    collaborator OTHER
  • University of Pecs

    collaborator OTHER
  • European Association for Palliative Care (EAPC)

    collaborator UNKNOWN
  • Universidade Católica Portuguesa

    collaborator OTHER
  • Hospice Villa Speranza

    collaborator OTHER
  • Radboud University Medical Center

    lead OTHER

Principal Investigators

  • Jeroen Hasselaar · Radboud University Medical Center (Radboudumc)

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-01
Primary Completion
2026-10-31
Completion
2027-08-31

Countries

  • Netherlands

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06259136 on ClinicalTrials.gov